Pfizer-BioNTech COVID-19 vaccine gains full U.S. regulatory approval
Go back to Pfizer-BioNTech COVID-19 vaccine gains full U.S. regulatory approval| (NASDAQ: BNTX) | Delayed: 98.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.66 | 52 Week High | $ | |||
| Open | $97.50 | 52 Week Low | $ | |||
| Day High | $99.58 | P/E | N/A | |||
| Day Low | $97.13 | EPS | $ | |||
| Volume | 4,941 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.64 | 52 Week High | $37.39 | |||
| Open | $27.62 | 52 Week Low | $28.25 | |||
| Day High | $27.81 | P/E | 16.75 | |||
| Day Low | $27.55 | EPS | $1.65 | |||
| Volume | 54,010 | |||||
